Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

Condition:   Heart Failure Interventions:   Drug: LCZ 696;   Drug: Placebo;   Drug: Para-aminohippurate;   Drug: Iohexol;   Drug: Aprepitant Sponsor:   Yale University Not yet recruiting

Source: ClinicalTrials.gov - December 2, 2020 Category: Research Source Type: clinical trials